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ABSTRACT
22q11 deletion is one of the most frequently encountered genetic syndromes. The phenotypic
spectrum shows a wide variability. We report a boy who presented at age 11.9 years with
seizures due to hypocalcemia as a result of hypoparathyroidism. FISH analysis revealed a het-
erozygote deletion at 22q11.2.  Positive findings for the syndrome were delayed speech devel-
opment due to velofacial dysfunction, recurrent croup attacks in early childhood due to latent
hypocalcemia and mild dysmorphic features. The findings of this patient indicate that 22q11
deletion syndrome may present with a wide spectrum of clinical findings and that this diagnosis
needs to be considered even in patients of older ages presenting with hypocalcemia.  
Conflict of interest: None declared
INTRODUCTION
22q11.2 deletion syndrome (22q11.2 DS)
is one of the most frequently encountered
interstitial deletion syndromes in the popu-
lation. The frequency is estimated as 1/4000-
5000.(1) It is usually sporadic; however,
autosomal dominant inheritance has been
reported in 10-20% of the patients. The phe-
notypic expression shows wide variabili-
ty.(2, 3) Congenital heart defect, typical
facial appearance, immune deficiency due
to thymic hypoplasia, palatal cleft, velofacial
dysfunction, hypocalcemia associated with
hypoparathyroidism, developmental and
behavioral problems are the main features
associated with the syndrome. 
In this paper we report a patient with
22q11.2 DS who presented at age 11.9 years
with hypocalcemia due to hypoparathy-
roidism, a condition which is unusual for
this age and usually is in the differential
diagnosis in early infancy. 
CASE REPORT
An 11.9 year old male patient who had
a generalized tonic seizure three days prior
to presentation was seen in our unit. He
was born at term by vaginal delivery,
weighing 3700 g. The developmental mile-
stones were reported to be delayed,. The
patient  walked at ~2 years of age and
uttered his first words at 2.5 years of age.
He was offered physical therapy at that
age by a pediatric neurologist. He was
investigated for recurrent wheezing attacks
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useat ~4 years of age and was diagnosed to
have gastroesophageal reflux (GER) and was
treated accordingly. He underwent ade-
noidectomy, tonsillectomy and lacrimal
canal dilatation. At 6 years of age the patient
had recurrent attacks of croup and was treat-
ed with steroids. He was diagnosed to have
Perthes disease at age ~9 years. According to
his family, his school performance was mod-
erate. Family history was unremarkable.
Physical examination revealed a coarse
facial appearance, with small ears, a narrow
forehead, and a long face with decreased ear
creases. The voice was hypernasal. Chvostek
and Trousseau signs were positive. Systemic
findings were otherwise normal. He
weighed 53 kg (0.9 SDS), measured 142 cm
(-1.2 SDS) in height and his body mass index
(BMI) was 26.5 kg/m2 (4.5 SDS). He was
pubertal with testicular volumes of 8 ml and
pubic hair at stage 4. 
Laboratory investigations presented in
Table 1 revealed hypocalcemia and hyper-
phosphatemia. Parathyroid hormone (PTH)
level was low. Thyroid hormones, cortisol and
prolactin levels were normal. Other biochem-
ical parameters, blood count and urine analy-
sis were normal. 24 hour urine calcium was
0.42 (mg/kg/day) (normal <4 mg/kg/day). 
A diagnosis of hypoparathyroidism was
considered. This diagnosis, suggested by the
clinical and biochemical findings, was found
to be associated with 22q11.2 DS, which was
shown by FISH as a heterozygote deletion.
Further investigations revealed a normal
echocardiography and normal B and T cell
functions (not given in detail). The parents
had normal FISH analysis, pointing to a spo-
radic mutation in our patient. Calcium
replacement therapy, combined with active
vitamin D was started.
DISCUSSION
Hypoparathyroidism and the resulting
hypocalcemia are among the main features
of 22q11.2 DS, and are observed in 70% of
individuals with this deletion.(4, 5) The
hypocalcemia may be of variable severity. In
the severest cases the hypocalcemia is con-
genital. However, latent hypoparathyroidism
is more frequent than persistent cases with
symptomatic hypocalcemia.(6, 7) In most
patients,  hypocalcemia resolves around one
year of age but recurs in childhood or in
adolescence. In latent hypoparathyroidism
PTH is secreted in sufficient quantities in
basal states and serum calcium (Ca) and
phosphorus (P) levels are normal. However,
when Ca intake is not sufficient, especially
when Ca requirements are high such as the
case in infancy, adolescence or pregnancy,
PTH secretion becomes inadequate and
hypocalcemia becomes evident.(7, 8, 9)
Recurrent croup attacks in our patient were
probably related to latent hypoparathy-
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Table 1: Serum biochemistry of the patient at presentation.
Results Normal Ranges
Total calcium (mg/dL) 6.3 8.8-10.8
Ionized calcium (mmol/L) 0.74 1.12-1.23
Phosphorus (mg/dL) 9 3.7-5.6
Alkaline phosphatase (IU/L) 244 145-420
Magnesium (mg/dL) 1.9 1.5-2.3
Albumin (g/dL) 4.8 4.0-5.3
pH 7.38 7.35-7.45
HCO3 (mEq/L) 24.9 22-29
PTH (pg/mL) 14.7 15-65
25 OH D3 (ng/mL) 26 10-30
1.25 (OH)2D3 (pg/mL) 61 16-65roidism which became decompensated dur-
ing puberty, due to increased calcium
demand which was not met by an adequate
PTH response. 
Another manifestation of the syndrome
in our patient was velopharyngeal dysfunc-
tion which resulted in hypernasal voice and
retardation in speech development.
Congenital heart defects and immune
deficiency, which are among other findings
reported for patients with 22q11 DS, were
not encountered in our patient. Congenital
asymmetric crying facies, caused by the
absence or hypoplasia of the depressor
anguli oris muscle on one side of the mouth,
has also been reported in 22q11 DS.(10, 11)
This finding  was not seen in our patient.   
There is no phenotype-genotype correla-
tion in 22q11 DS.(12, 13, 14, 15) Wide phe-
notypic variabilities are seen even among
the family members with same muta-
tions.(16, 17, 18) Thus early diagnosis may
be difficult. A thorough clinical observation
is necessary not to misdiagnose the cases
with atypical findings. It is easy to make the
diagnosis of 22q11 DS in the presence of
congenital heart defects, palatal defect and
symptomatic early onset hypocalcemia.
However, in the absence of these major
findings such as was the case in our patient,
22q11 DS must be considered in the differ-
ential diagnosis of developmental delay,
velopharingeal dysfunction, recurrent
attacks of croup and mild dysmorphic fea-
tures. Early diagnosis may prompt early
management  of learning difficulties. 
In conclusion, hypocalcemia due to
latent hypoparathyroidism in late childhood
and in puberty should be considered in the
differential diagnosis of 22q11 DS.
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